PI
CRL icon

PineBridge Investments’s Charles River Laboratories CRL Stock Holding History

PineBridge Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,029
Closed -$2.56M – 598
2025
Q1 		$2.56M Sell
17,029
-95,596
-85% -$16M 0.02% 397
2024
Q4 		$20.8M Sell
112,625
-23,584
-17% -$4.54M 0.16% 134
2024
Q3 		$26.8M Buy
136,209
+7,823
+6% +$1.63M 0.2% 118
2024
Q2 		$26.5M Buy
128,386
+4,497
+4% +$1.02M 0.21% 109
2024
Q1 		$33.6M Buy
123,889
+23,508
+23% +$5.61M 0.27% 82
2023
Q4 		$23.7M Buy
100,381
+18,849
+23% +$3.71M 0.22% 119
2023
Q3 		$16M Buy
81,532
+7,278
+10% +$1.49M 0.18% 134
2023
Q2 		$15.6M Sell
74,254
-2,442
-3% -$486K 0.17% 136
2023
Q1 		$15.5M Buy
76,696
+6,676
+10% +$1.51M 0.17% 147
2022
Q4 		$15.3M Buy
70,020
+13,958
+25% +$3.05M 0.18% 150
2022
Q3 		$11M Buy
56,062
+3,286
+6% +$709K 0.14% 173
2022
Q2 		$11.3M Buy
52,776
+1,694
+3% +$414K 0.14% 173
2022
Q1 		$14.5M Buy
51,082
+24,267
+90% +$7.48M 0.16% 156
2021
Q4 		$10.1M Sell
26,815
-3,428
-11% -$1.33M 0.1% 202
2021
Q3 		$12.5M Sell
30,243
-21,169
-41% -$8.79M 0.15% 156
2021
Q2 		$19M Buy
51,412
+14,700
+40% +$4.91M 0.22% 114
2021
Q1 		$10.6M Hold
36,712
– – 0.14% 194
2020
Q4 		$9.17M Sell
36,712
-4,986
-12% -$1.19M 0.14% 179
2020
Q3 		$9.44M Buy
41,698
+6,914
+20% +$1.43M 0.16% 149
2020
Q2 		$6.07M Buy
+34,784
New +$5.55M 0.12% 198
2014
Q2 		– Sell
-3,249
Closed -$196K – 1068
2014
Q1 		$196K Sell
3,249
-1,011
-24% -$58.9K 0.01% 765
2013
Q4 		$226K Sell
4,260
-1,975
-32% -$99.2K 0.01% 744
2013
Q3 		$288K Sell
6,235
-5,233
-46% -$240K 0.01% 424
2013
Q2 		$471K Buy
+11,468
New +$491K 0.01% 371

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

PineBridge Investments's CRL Position: Q2 2025 in Review

PineBridge Investments sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 17,029 shares — an estimated $2.56M sold.

PineBridge Investments first reported a position in CRL in Q2 2013 and held it in 24 quarters. The position peaked at $33.6M in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • PineBridge Investments reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • PineBridge Investments sold 17,029 Charles River Laboratories shares in Q2 2025, an estimated $2.56M.
  • PineBridge Investments first reported a position in Charles River Laboratories in Q2 2013 and held it in 24 quarters.
  • PineBridge Investments's Charles River Laboratories position peaked at $33.6M in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on PineBridge Investments's 13F filing for Q2 2025, filed 13 Aug 2025.